Clinical trials
Terminated Phase 2 Immune System Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2019 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 2 |
| Novartis Pharmaceuticals | 2 |
| Seagen Inc. | 2 |
| miRagen Therapeutics, Inc. | 2 |
| Amgen | 1 |
| Eli Lilly and Company | 1 |
| European Association of Urology Research Foundation | 1 |
| Forte Biosciences, Inc. | 1 |
| Gilead Sciences | 1 |
| Myrexis Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immune System Diseases | 16 |
| Immunoproliferative Disorders | 5 |
| Lymphatic Diseases | 5 |
| Lymphoma | 5 |
| Lymphoma, Non-Hodgkin | 5 |
| Neoplasms | 5 |
| Lymphoproliferative Disorders | 4 |
| Autoimmune Diseases | 3 |
| Connective Tissue Diseases | 3 |
| Dermatitis | 3 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.